Toritz 500 mg Injection
  1. Home
  2. Pharma Products
  3. Torrent Pharmaceuticals Ltd
  4. Toritz 500 mg Injection

Toritz 500 mg Injection

Toritz 500 mg Injection contains rituximab 500 mg, a monoclonal antibody that targets CD20-positive B cells. It is used for certain blood cancers and selected autoimmune conditions under specific treatment protocols. The medicine is administered by intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Rituximab binds to the CD20 antigen on B cells and helps the immune system eliminate these cells. Toritz is used in specific regimens for conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. The 500 mg presentation is supplied as a 50 mL injection containing rituximab at 10 mg/mL. Treatment dose and infusion schedule are determined by the treating physician according to the patient’s condition and prescribed protocol.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Dosage Form Injection
Concentration 10 mg/mL
Volume 50 mL
Manufacturer Torrent Pharmaceuticals Ltd

Product Also Known As

Toritz 500 mg Injection, Toritz 500mg Injection, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL Injection, Rituximab Infusion, Anti-CD20 Monoclonal Antibody, Rituximab Anticancer Injection

Related products